Target intelligence / Profile preview

Heme detoxification

Molecular classification
Other
01

Overview

Heme detoxification is a biological process responsible for converting or neutralizing free heme, a pro-oxidant and cytotoxic molecule, commonly released during hemoglobin digestion. In malaria parasites such as Plasmodium falciparum, detoxification primarily proceeds via crystallization of heme into hemozoin, an inert polymer, within the digestive vacuole. Similar processes occur in other blood-feeding organisms and mammals, although strategies differ: mammals enzymatically degrade heme to bilirubin and excrete it, while some animals encapsulate heme in mineral particles to render it inert. Because efficient detoxification is essential for parasite survival, heme detoxification pathways and molecules involved (e.g., heme detoxification proteins, transporters like HrtBA) are targets for antimalarial drugs such as chloroquine and artemisinin, which act by disrupting this process. The process is not itself a druggable target in the conventional sense but refers to a set of biochemical strategies involving multiple molecular players. There is a fundamental issue with listing “heme detoxification” as a target molecule: it is a process, not a discrete, canonical target. Any attempt to obtain structured target-level data for “heme detoxification” will need to focus on specific molecular components such as “Heme detoxification protein (HDP)”, “HrtBA transporter”, or “heme crystallization pathway” for accurate data abstraction.

Other names
heme neutralizationheme clearanceheme detoxification pathway
02

Mechanism of action

Inhibition of heme polymerization to hemozoin; Disruption of heme crystallization; Binding free heme to prevent toxicity

03

Biological functions

DetoxificationCellular protectionPrevention of oxidative stressDefense against heme toxicity
04

Disease associations

InfectionMalariaBlood-feeding parasite infectionHemolytic disordersGastrointestinal disease
05

Safety considerations

Drug resistance in malaria parasitesOff-target toxicity of inhibitorsPotential host toxicity if heme detoxification is disrupted
06

Interacting drugs

Chloroquine

4 more in the full profile.

Beyond the preview

Go deeper on Heme detoxification.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heme detoxification.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call